A co-evolutionary perspective on the drivers of international sourcing of pharmaceutical R&D to India

Journal of Economic Geography

Volumn 13, Issue 4, 2013, Pages 677-700

  Haakonsson, Stine Jessen ^a   Ørberg Jensen, Peter D ^a   Mudambi, Susan M ^b  

^a Department of International Economics and Management   (Denmark)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Captive offshoring; Co evolution; Location; Offshore outsourcing; R D internationalization

Indexed keywords

ECONOMIC DEVELOPMENT; ECONOMIC INTEGRATION; ECONOMIC THEORY; MULTINATIONAL ENTERPRISE; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; STRATEGIC APPROACH;

INDIA;

EID: 84878909086     PISSN: 14682702     EISSN: 14682710     Source Type: Journal    
DOI: 10.1093/jeg/lbs018     Document Type: Article

References (93)

1. Aggarwal, A. (2004) Strategic Approach to Strengthening the International Competitiveness in Knowledge Based Industries: The Indian Pharmaceutical Industry. RIS Discussion Paper No. 80/2004, Research and Information System for Developing Countries (RIS). New Delhi.
2. Archibugi, D., Iammarino, S. (1999) The policy implications of globalisation of innovation. In D. Achibugi, J. Howells, J. Michie (eds) Innovation Policy in a Global Economy. Cambridge: Cambridge University Press.
3. Kearney, A. T. (2005) FDI Confidence Index. Chicago: A. T. Kearney.
4. Kearney, A. T. (2007) Offshoring for Long-Term Advantage: The 2007 Global Services Location Index. Chicago: A. T. Kearney.
5. Athreye, S., Cantwell, J. (2007) Creating competition? Globalisation and the emergence of new technology producers. Research Policy, 36: 209-226.
6. Beugelsdijk, S., McCann, P., Mudambi, R. (2010) Introduction: place, space and organization-economic geography and the multinational enterprise. Journal of Economic Geography, 10: 485-493.
7. Birkinshaw, J., Hood, N. (1998) Multinational Corporate Evolution and Subsidiary Development. New York: St. Martin's Press.
8. Boschma, R. A., Frenken, K. (2006) Why is economic geography not an evolutionary science? Towards an evolutionary economic geography. Journal of Economic Geography, 6: 273-302.
9. Bosker, M., Garretsen, H. (2009) Economic development and the geography of institutions. Journal of Economic Geography, 9: 295-328.
10. Buckley, P. J. (2009) Internalisation thinking: from the multinational enterprise to the global factory. International Business Review, 18: 224-235.
11. Buckley, P. J., Ghauri, P. N. (2004) Globalisation, economic geography and the strategy of multinational enterprises. Journal of International Business Studies, 35: 81-98.
12. Business Week, (2008) Big Pharma's R&D Booster Shop. Business Week, 11 June. Available online at: www.businessweek.com [Accessed 17 August 2010].
13. Cantwell, J., Dunning, J. H., Lundan, S. M. (2010) An evolutionary approach to understanding international business activity: the co-evolution of MNEs and the institutional environment. Journal of International Business Studies, 41: 567-586.
14. Cantwell, J., Mudambi, R. (2005) MNE competence-creating subsidiary mandates. Strategic Management Journal, 26: 1109-1128.
15. Cekola, J. (2007) Outsourcing drug investigations to India: a comment on U.S., Indian, and international regulation of clinical trials in cross-border pharmaceutical research. Northwestern Journal of International Law and Business, 28: 125-145.
16. Chaudhuri, S. (2005) The WTO and India's Pharmaceutical Industry: Patent Protection, TRIPS, and Developing Countries. New Delhi: Oxford University Press.
17. Cheng, J. L. C., Henisz, W. J., Roth, K., Swaminathan, A. (2009) Advancing interdisciplinary research in the field of international business: prospects, issues and challenges. Journal of International Business Studies, 40: 1070-1074.
18. Coe, N. M., Dicken, P., Hess, M. (2008) Global production networks: realizing the potential. Journal of Economic Geography, 8: 271-295.
19. Contractor, F. J., Kumar, V., Kundu, S. K., Pedersen, T. (2010) Reconceptualizing the firm in a world of outsourcing and offshoring: the organizational and geographical relocation of highvalue company functions. Journal of Management Studies, 47: 1417-1433.
20. Contractor, F. J., Mudambi, S. M. (2008) The influence of human capital investment on the exports of services and goods: an analysis of the top 25 services outsourcing countries. Management International Review, 48: 433-445.
21. Dicken, P. (2007) Global Shift-Mapping the Changing Contours of the World Economy, 5th edn. London: Sage.
22. DiMasi, J. A., Hansen, R. W., Grabowski, H. G. (1991) Cost of innovation in the pharmaceutical industry. Journal of Health Economics, 10: 107-142.
23. DiMasi, J. A., Hansen, R. W., Grabowski, H. G. (2003) The price of innovation: new estimates of drug development costs. Journal of Health Economics, 22: 151-185.
24. Dunning, J. H. (1988) The eclectic paradigm of international production: a restatement and some possible extensions. Journal of International Business Studies, 19: 1-31.
25. Dunning, J. H. (2009a) 2008 decade award winning article-location and the multinational enterprise: a neglected factor. Journal of International Business Studies, 40: 5-19.
26. Dunning, J. H. (2009b) Location and the multinational enterprise: John Dunning's thoughts on receiving the Journal of International Business Studies 2008 Decade Award. Journal of International Business Studies, 40: 20-34.
27. Dunning, J. H., Lundan, S. M. (2008) Multinational Enterprises and the Global Economy. Cheltenham: Edward Elgar Publishing.
28. Dunning, J. H., Narula, R. (1996) The investment development path revisited: some emerging issues. In J. H. Dunning, R. Narula (eds) Foreign Direct Investment and Governments: Catalysts for Economic Restructuring. London: Routledge.
29. Ernst, D. (2006) Innovation Offshoring. Asia's Emerging Role in Global Innovation Networks. East West Center Special Reports No. 10.
30. Essletzbichler, J., Rigby, D. L. (2007) Exploring evolutionary economic geographies. Journal of Economic Geography, 7: 549-571.
31. Farrell, D., Laboissière, M. A., Rosenfeld, J. (2006) Sizing the emerging global labor market: rational behavior from both companies and countries can help it work more efficiently. Academy of Management Perspectives, 20: 23-34.
32. Fifarek, B. J., Veloso, F. M. (2010) Offshoring and the global geography of innovation. Journal of Economic Geography, 10: 559-578.
33. Fortune Magazine, (2007) Global 500. Fortune Magazine, July 23, Available online at: http://money.cnn.com/magazines/fortune/global500/2007/industries/21/1.html [Accessed 26 May 2010].
34. Gammeltoft, P. (2006) Internationalisation of R&D: trends, drivers and managerial challenges. International Journal of Technology and Globalisation, 2: 177-199.
35. Garnier, J.-P. (2008) Rebuilding the R&D engine in big pharma. Harvard Business Review, 86: 68-76.
36. Gassmann, O., von Zedtwitz, M. (1999) New concepts and trends in international R&D organization. Research Policy, 28: 231-150.
37. Gereffi, G. (1983) The Pharmaceutical Industry and Dependency in the Third World. New Jersey: Princeton University Press.
38. Government of India, (2005) The Patents (Amendment) Act, 2005. The Gazette of India Extraordinary. New Delhi.
39. Graf, M., Mudambi, S. M. (2005) The outsourcing of IT-enabled business processes: a conceptual model of the location decision. Journal of International Management, 11: 253-268.
40. Haakonsson, S. J. (2008) Governance and upgrading in the global value chain for pharmaceuticals-with case studies on Uganda and India. PhD thesis, University of Copenhagen.
41. Haakonsson, S. J. (2009a) The changing governance structures of the global pharmaceutical value chain. Competition and Change, 13: 75-95.
42. Haakonsson, S. J. (2009b) How does "linking up with global buyers" impact the prospects for upgrading in pharmaceuticals? The case of India. In E. Rugraff, D. Sanchez-Ancochea, A. Sumner (eds) Transnational Corporations, Government Policy and Development: Towards New Concepts and Methodologies. Basingstoke: Palgrave.
43. Haakonsson, S. J., Richey, R. A. (2007) TRIPs and public health: the Doha declaration and Africa. Development Policy Review, 25: 71-91.
44. Henisz, W. (2000) The institutional environment for multinational investment. Journal of Law, Economics, and Organization, 16: 334-364.
45. ICRA, (2004) The Indian Pharmaceutical Industry. Industry Watch Series. New Delhi: ICRA.
46. ICRA, (2005) Pharmaceuticals: The Indian Pharmaceutical Industry. ICRA Sector Analysis. New Delhi: ICRA.
47. IMS Health, (2004) Global Pharmaceutical Perspectives. IMS Intelligence 360.
48. Jensen, P. D. ø. (2009) A learning perspective on the offshoring of advanced services. Journal of International Management, 15: 181-193.
49. Jensen, P. D. ø., Pedersen, T. (2011) The economic geography of offshoring: the fit between activities and local context. Journal of Management Studies, 48: 352-372.
50. Jones, O. (2000) Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D. British Journal of Management, 11: 341-356.
51. Kenney, M., Massini, S., Murtha, T. P. (2009) Offshoring administrative and technical work: new fields for understanding the global enterprise. Journal of International Business Studies, 40: 887-900.
52. Kermani, F., Langer, E. S. (2007) Outsourcing is key to future pharmaceutical R&D strategy. Pharmaceutical Technology Europe, 19: 14-17.
53. Khanna, T., Palepu, K. G. (2010) Winning in Emerging Markets -A Road Map for Strategy and Execution. Cambridge, MA: Harvard Business Press.
54. Kostova, T., Roth, K., Dacin, M. T. (2008) Institutional theory in the study of multinational corporations: a critique and new directions. Academy of Management Review, 33: 994-1006.
55. Kotabe, M. (1992) Global Sourcing Strategy: R&D, Manufacturing and Marketing Interfaces. New York: Quorum Books.
56. Kotabe, M., Mol, M. J., Ketkar, S. (2008) An evolutionary stage model of outsourcing and competence destruction: a triad comparison of the consumer electronics industry. Management International Review, 48: 65-93.
57. Koza, M. P., Lewin, A. Y. (1998) The co-evolution of strategic alliances. Organizational Science, 9: 255-264.
58. Kuemmerle, W. (1999) Foreign direct investment in industrial research in the pharmaceutical and electronics industries. Research Policy, 28: 179.
59. Kumra, G., Mitra, P., Pariche, C. (2007) India Pharma 2015. Unlocking the potential of the Indian Pharmaceuticals Market. McKinsey and Company Report.
60. Lewin, A. Y., Long, C. P., Carroll, T. N. (1999) The coevolution of new organizational forms. Organization Science, 10: 535-550.
61. Lewin, A. Y., Massini, S., Peeters, C. (2009) Why are companies offshoring innovation? The emerging global race for talent. Journal of International Business Studies, 40: 901-925.
62. MacGarvey, A. (2009) The changing face of outsourcing. Pharmaceutical Technology Europe, 2009: 98.
63. Maiti, R., Raghavendra, M. (2007) Clinical trials in India. Pharmacological Research, 56: 1-10.
64. Malthore, P., Lofgren, H. (2004) India's pharmaceutical industry: hype or high tech take off? Australian Health Review, 28: 182-193.
65. Manning, S., Lewin, A. Y., Massini, S. (2008) A dynamic perspective on next-generation offshoring: the global sourcing of science and engineering skills. Academy of Management Perspectives, 22: 35-55.
66. McCann, P., Mudambi, R. (2005) Analytical differences in the economics of geography: the case of the multinational firm. Environment and Planning A, 37: 1857-1876.
67. McKelvey, B. (1997) Quasi-natural organization science. Organization Science, 8: 351-380.
68. Meyer, K. E., Peng, M. W. (2005) Probing theoretically into Central and Eastern Europe: transactions, resources, and institutions. Journal of International Business Studies, 36: 600-621.
69. Mikkola, J. H. (2003) Modularity, component outsourcing, and inter-firm learning. R&D Management, 33: 439-454.
70. Miller, J. (2009) The future of pharmaceutical CMC outsourcing. A roundtable with pharma majors Pfizer and Johnson and Johnson. Pharmaceutical Technology Outsourcing Resources, 2009: 20-25.
71. Mol, M. J. (2005) Does being R&D intensive still discourage outsourcing? Evidence from Dutch manufacturing. Research Policy, 34: 571-582.
72. Mudambi, R. (2008) Location, control and innovation in knowledge-intensive industries. Journal of Economic Geography, 8: 699-725.
73. Mudambi, S. M., Tallman, S. (2010) Make, buy or ally? Theoretical perspectives on knowledge process outsourcing through alliances. Journal of Management Studies, 47: 1434-1456.
74. Nassimbeni, G., Sartor, M. (2008) Sourcing in India-Strategies and Experiences in the Land of Service Offshoring. Houndsmill: Palgrave Macmillan.
75. OPPI, (2007) 41st Annual Report: 2006-2007. Organisation of Pharmaceutical Producers in India, Mumbai.
76. Phelps, N. A. (2008) Cluster or capture? Manufacturing foreign direct investment, external economies and agglomeration. Regional Studies, 42: 457-473.
77. Phelps, N. A., Wood, A. (2006) Lost in translation? Local interests, global actors and inward investment regimes. Journal of Economic Geography, 6: 493-515.
78. Phelps, N. A., Wu, F. (2009) Capital's search for order: foreign direct investment and modes of social order in East and Southeast Asia. Political Geography, 28: 44-54.
79. Porter, T. B. (2006) Coevolution as a research framework for organizations and the natural environment. Organization & Environment, 19: 479-504.
80. Raggett, T. (1996) GATT and Patent Reform: The Global Strengthening of Patent Protection and the Implications for the Pharmaceutical Industry. Financial Times Management Report. London: Financial Times Pharmaceuticals and Healthcare Publishing.
81. Rangnekar, A. (2007) Longitudinal Study of the Strategic Responsiveness of the Survivors of Big Pharma in 1995 and 2004, Under Conditions of Consolidation in the Global Pharmaceutical Market. Unpublished PhD thesis, Mumbai: NMIMS University.
82. Reuters, (2010) Big Pharma's Stalled R&D Machine. Reuters Special Report. 16 June 2010.
83. Stringfellow, A., Teagarden, M. B., Nie, W. (2008) Invisible costs in offshoring services work. Journal of Operations Management, 26: 164-179.
84. Sturgeon, T., Van Biesebroeck, J., Gereffi, G. (2008) Value chains, networks and clusters: reframing the global automotive industry. Journal of Economic Geography, 8: 297-321.
85. Taggart, J. (1993) The World Pharmaceutical Industry. London: Routledge.
86. UNCTAD, (2005) World Investment Report: Transnational Corporations and the Internationalization of R&D. Geneva: UNCTAD.
87. Van Arnum, P. (2009) Global outsourcing. A roundtable of contract manufacturers. Pharmaceutical Technology Outsourcing Resources, 2009: 26-36.
88. Vernon, R. (1966) International investment and international trade in the product cycle. Quarterly Journal of Economics, 80: 190-207.
89. Volberda, H. W., Lewin, A. Y. (2003) Co-evolutionary dynamics within and between firms: from evolution to co-evolution. Journal of Management Studies, 40: 2111-2136.
90. von Zedtwitz, M., Gassmann, O., Boutellier, R. (2004) Organizing global R&D: challenges and dilemmas. Journal of International Management, 10: 21-49.
91. Wright, M., Filatotchev, I., Hoskisson, R. E., Peng, M. W. (2005) Strategy research in emerging economies: challenging the conventional wisdom. Journal of Management Studies, 42: 1-33.
92. WTO, (2007) Trade Policy Review, Report by India. WT/TPR/S/182.
93. WTO, (2011) www.wto.org [Accessed 30 August 2011].